The novel class of GLP-1 agonist medication and GIP dual medications, such as tirzepatide, semaglutide, and the newly introduced retatrutide, provide promising improvements in the management . Despite all https://tb500461839.free-blogz.com/91453040/semaglutide-a-comparative-review